BackLiminal Biosciences Overview

Liminal Biosciences Other Assets

Liminal Biosciences's other assets is $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer trimmed avg / median

Loading

Liminal Biosciences Other Assets History

Loading

Liminal Biosciences vs. peers: Other Assets Comparison

Loading

Liminal Biosciences Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Liminal Biosciences (LMNL) FAQ

Liminal Biosciences (LMNL) currently reports a other assets of $0 as of June 2023. In the prior-year period, the figure was $0. Use the charts on this page to explore Liminal Biosciences's other assets history and peer comparisons.

Liminal Biosciences's other assets changed from $0 to $0 (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Liminal Biosciences reported $0 in other assets as of June 2023. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Liminal Biosciences, and consider following LMNL for alerts when major investors trade the stock.

Liminal Biosciences is classified in the Healthcare sector. On other assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LMNL with unrelated industries.